1[1]Kuinose M,Iwagaki H,Morimoto Y.Calcineurin antagonists inhibit interferon-gamma production by down regulation of interleukin-18 in human mixed lymphocyte reactions[J].Acta Med Okyama,2000,54(5):201～209 被引量：1
2[2]Xu D,Trajkovic V,Hunter D,et al.IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background[J].Eur J Immunol,2000,30(11):3147～3156 被引量：1
4[4]Jander S,Stoll G.Increased serum levels of the interferon-γ-inducing cytokine interleukin-18 in myasthenia gravis[J].Neurology,2002,59(2):287～289 被引量：1
2Rey RD, Buzzi AE, Astudillo MA, et al. Diagnosis and treatment of myasthenia gravis. Experience 1974-1992[J]. Medicina (B Aires), 1995,55(1) :11-20. 被引量：1
3Kott E, Hahn T, Huberman M, et al. Interferon system and natural killer cell activity in myasthenia gravis[J]. Q J Med, 1990,76 (281): 951-960. 被引量：1
4Confalonieri P, Antozzi C, Cornelio F, et al. Immune activation in myasthenia gravis : soluble interleukin-2 receptor, interferon-gamma and tumor necrosis factor-alpha levels in patients serum[J]. J Neuroimmunol, 1993,48(1) :33-36. 被引量：1
5Huang WX, Huang P, Fredrikson S, et al. Decreased mRNA expression of TNF-alpha and IL-10 in non-stimulated peripheral blood mononuclear cells in myasthenia gravis[J]. Eur J Neurol, 2000,7(2):195-202. 被引量：1
6Jander S,Stoll G. Increased serum levels of the interferon-gamma-inducing cytokine interleukin-18 in myasthenia gravis[J]. Neurology, 2002,59(2) :287-289. 被引量：1
7Sligh JE Jr, Ballantyne CM, Rich SS, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1 [J].Proc Natl Acad Sci U S A, 1993,90(18)z8529-8533. 被引量：1
8Khoury SJ, Orav E J, Guttmann CR, et al. Changes in serum levels of ICAM and TNF-ρ correlate with disease activity in multiple sclerosis[J]. Neurology,1999,53(4) :758-764. 被引量：1
